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Abstract
Magnetic fluid hyperthermia (MFH) therapy uses the magnetic component of electromagnetic fields in the radiofrequency
spectrum to couple energy to magnetic nanoparticles inside tumors. In MFH therapy, magnetic fluid is injected into tumors
and an alternating current (AC) magnetic flux is applied to heat the magnetic fluid- filled tumor. If the temperature can be
maintained at the therapeutic threshold of 42uC for 30 minutes or more, the tumor cells can be destroyed. Analyzing the
distribution of the magnetic fluid injected into tumors prior to the heating step in MFH therapy is an essential criterion for
homogenous heating of tumors, since a decision can then be taken on the strength and localization of the applied external
AC magnetic flux density needed to destroy the tumor without affecting healthy cells. This paper proposes a methodology
for analyzing the distribution of magnetic fluid in a tumor by a specifically designed giant magnetoresistance (GMR) probe
prior to MFH heat treatment. Experimental results analyzing the distribution of magnetic fluid suggest that different
magnetic fluid weight densities could be estimated inside a single tumor by the GMR probe.
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Introduction
Hyperthermia therapy is a cancer treatment technique that uses
heat to destroy tumors. Temperatures in the range of 42–45uC are
known to kill cancer cells while having no, or minimal, effect on
healthy cells [1–5]. The most common method of heating tumors
is by electromagnetic radiation [6]. Two disadvantages of
electromagnetic radiation are the inhomogeneous heating of
tumor tissue and the heating of healthy tissues, due to the
variation in the electrical properties of tissues. Inhomogeneous
heating can result in under-treatment of a tumor; while heating of
healthy tissues can cause burns, blisters and discomfort. Magnetic
fluid hyperthermia (MFH) seeks to address these two issues by
injecting magnetic nanoparticles into the tumor region, thereby
selectively targeting tumor tissue and depositing heat in a localized
manner [7–10]. The injected region is heated by the application of
an alternating (AC) magnetic flux density. The energy absorbed
from the AC magnetic flux is transformed to heat due to Neel
relaxation and Brownian motion of the magnetic nanoparticles
[7]. Such localized treatment, which results in very high spatial
selectivity in the target region, cannot be achieved with radiation-
based therapies because unwanted heating due to the electrical
conductivity of healthy tissues cannot be avoided during radiation.
Moreover, unlike radiation-based therapies, MFH can target
deep-seated tumors since the penetration depth does not depend
on the frequency.
The distribution of the magnetic fluid, once injected into a
tumor site, depends on many factors, such as particle size, surface
characteristics and the dosage of the injected magnetic fluid,
heterogeneity of the tumor and surrounding tissue, size and pH of
the tumor, blood flow in the tumor and surrounding areas, and the
applied magnetic flux strength [2,8,11–15]. For effective MFH
treatment, tumors must be heated uniformly [9,10,15–19]. Given
that the applied magnetic flux density is uniform, the magnetic
fluid injected into the affected area must also be uniform for
homogenous heating of the tumor [20–24]. However, magnetic
fluid injected into tumor sites can spread into neighboring tissue
[25–27], which can lead to an inhomogeneous distribution of the
fluid, and a decrease in the density of the magnetic fluid inside the
tumor; hence, the relative permeability of surrounding, healthy
tissue cannot be assumed to be 1. The application of an external
AC magnetic flux density could then cause inhomogeneous
heating of the tumor and possibly heat surrounding healthy cells,
leading to possible necrosis of healthy tissue [28,29]. However, the
goal of MFH therapy is to protect healthy tissue from damage
while destroying tumor cells [30]. Since the specific heat capacity
generated is directly proportional to the density of the magnetic
fluid, it is critical to check and confirm the distribution of the
injected magnetic fluid [31–34].
The most common method of assessing and controlling
temperature in MFH therapy is by the use of thermocouples or
fiber-optical thermometers that are inserted by the surgeon into
the tumor to measure the temperature [35,36]. This method, while
inexpensive, is not very accurate and requires magnetic resonance
imaging (MRI) or computer tomography (CT) scans to locate the
presence of magnetic fluid. MRI and CT scans are also directly
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used to estimate temperature, in a non-invasive manner, but these
instruments are both bulky and expensive to use. Besides, large
errors may be caused in the MRI due to uncertainty in the
reference position which is caused by movement of the patient;
from breathing/heartbeat to sudden involuntary movements.
Several other methods that could be used to monitor temperature
also have limitations. For instance, the density difference between
bones and organs make it difficult for ultrasound to measure
temperature. It is also difficult to integrate fluorescent and optical
films into a surgical setup, and superconducting quantum
interference devices, while being sensitive to minute magnetic
fields, require large liquid helium cryostats for operation in
addition to being expensive [37]. Moreover, using these methods
during hyperthermia therapy might influence the temperature
readout.
In this paper, we describe a giant magnetoresistance (GMR)
probe designed to be inserted into the vicinity of the tumor tissue,
in a minimally-invasive way, to analyze the distribution of the
magnetic fluid inside the tumor. The distribution analysis is
performed prior to the heating step in MFH therapy, at much
lower magnitudes (,0.5 mT) and frequencies (,1000 Hz) than
those typically used in MFH therapy (2–30 mT and 0.1–10 MHz).
The analysis of the magnetic fluid distribution in the injected area
allows the strength, frequency and localization of the applied
external AC magnetic flux density needed to destroy the tumor to
be determined without affecting healthy cells. Furthermore, the
distribution analysis identifies if and where inside the tumor the
magnetic fluid is inhomogeneous. In such a case, procedures such
as multi-site injections can be used to increase the homogeneity of
the magnetic fluid distribution inside the tumor [38–40].
Compared with the temperature measurement methods men-
tioned above, the method explored in this paper indirectly gives
information about the temperature; the probe described here can
be used to map the distribution of specific heat capacity, thus
providing information about the temperature to assess the risks
associated with the length of therapy and temperature elevation. It
is also possible to use the probe to perform post-therapy analysis of
the distribution of any remaining magnetic fluid at the site. Such
information would allow the surgeon to determine how much
more magnetic fluid would be required for ensuing therapy and
also to monitor the fate of the magnetic fluid after treatment.
The probe proposed in this paper is designed to be small and
lightweight. It must also be highly sensitive with excellent spatial
resolution; critically important features when measuring very small
changes in magnetic flux densities inside tumors. Moreover, the
equipment necessary to process, read out and interpret the signals
from the probe is simple and inexpensive. The probe has a fast
response and can be operated continuously. Its maintenance cost is
low; it is durable, stable and minimally invasive. The USB
interface of the probe provides compatibility with standard
interfaces; it can therefore pass seamlessly from engineering
production to the operating theatre with minimal fuss.
Materials and Methods
1. Analytical Basis for Estimating the Weight Density of
Magnetic Fluid inside Tumors
One of the most important considerations in MFH therapy is
the heat capacity required to damage or destroy cancer cells
[41,42]. Heat capacity, Q (W/ml), can be calculated as
Q~kmfDwB
2 ð1Þ
where km = 3.14610
23 (W/Hz/(mgFe/ml)/T2/ml), f is the excit-
ing frequency (Hz), Dw is the weight density of the magnetic fluid
(mgFe/ml) and B is the amplitude of the applied magnetic flux
density (T). km is a coefficient that depends on the properties of the
magnetic fluid. The value for km was obtained by experimentation
with ResovistH, a clinically approved magnetic fluid that includes
superfine iron oxide nanoparticles coated with carboxydextran.
In general, equation (1) can be used to determine the heat
capacity for effective treatment unless the tumor is close to large
vessels, in which case the ‘‘bio-heat’’ equation that takes into
account heat depletion due to blood perfusion should be used [43].
Once injected into tumors, Dw will depend on the retention of
magnetic fluid by the affected cells. Magnetic fluid injected into a
target site spreads to surrounding tissue, and also drains through
blood vessels and lymph nodes. However, it must be noted that
tumor cells generally absorb nine times more magnetic particles
than normal cells, though this uptake may depend on several
factors such as cell type and nanoparticle coating [44]. Several
methods have been used to increase the retention of magnetic
nanoparticles in affected cells, for example coupling magnetic
nanoparticles to tumor-specific ligands such as antibodies, slow
infiltration, and repeated multi-site injections [7].
Atkinson and Brezovich proposed a maximum limit on the
product H6f= 4.856108 Am21Hz based on patient discomfort
nearly 20 years ago [45,46]. In this product, H is the magnetic field
in A/m and f is the frequency in Hz. Their test was based on the
patient withstanding the treatment for more than one hour without
any major discomfort. This value continues to be used as the initial
criterion for using magnetic fields to apply heat to patients [34,47].
Assuming a typical frequency of 100 kHz and a specific heat
capacity of 0.1 W/ml [8,9,15–18,22,24,25,28,47], a magnetic field
of 4850 A/m or 6.1 mT is obtained according to the Atkinson and
Brezovich limit. If the solution is ResovistH, then a value of
8.55 mgFe/ml or 0.855% is obtained for Dw. This value should be
considered as an indication rather than an absolute limit. In fact, all
the values used for this calculation should not be considered as a
substitute for the proper measurement of clinical tolerability under
therapeutic conditions. The temperature increase over a period of
time is an essential parameter in MFH. However, the increase does
not solely depend on Q; several other clinical factors, such as the
heterogeneity of the tumor and surrounding tissue, the size and pH
of the tumor, blood flow in the tumor and surrounding areas, as well
as heat radiation influence the temperature increase.
Consider the situation shown in Figure 1. An ellipsoidal cavity
filled with magnetic fluid is placed under a uniform magnetic flux
density. Given that the outside environment is air with m*= 1, and
that the magnetic fluid has m* slightly greater than 1, magnetic flux
lines will converge and concentrate at the magnetic fluid filled
ellipsoidal cavity. If a magnetic flux density, B0, is applied then the
magnetic flux density in the cavity, B1 will change according to
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is based on permeance calculations [42]; hs
is the space factor for spherical magnetite (0.523), cf is the specific
gravity of magnetic fluid (4.58) and Cd is a coefficient (theoretically
4).
The basis for estimating Dw is the difference in magnetic flux
density inside, (B1), and outside, (B0), a tumor, when the tumor is




into (4) and for Dw,,1, the change
in magnetic flux density (d~
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The most important points to be observed from equation (5) are
that the change in the magnetic flux density is proportional to the
weight density, but independent of the shape and/or size of
magnetic nanoparticles in the magnetic fluid. However, the shape of
the cavity enclosing the magnetic fluid influences d; this is expressed
in equation (5) as the demagnetizing factor (N). N depends on the
aspect ratio of the cavity, s; for an ellipsoidal cavity s = major axis
b/minor axis a, as shown in Figure 1 [49]. During tumor heating in
MFH therapy, the magnetic fluid spreads after being injected which
means that m* and Dw are bound to vary inside the tumor as
opposed to being uniform, thus forming the basis for this research.
2. A Numerical Model to Analyze the Distribution of
Magnetic Fluid inside Tumors
In the previous section a relationship was obtained between d
and Dw, assuming that the magnetic fluid distribution was uniform
inside the ellipsoidal cavity. However, in a realistic clinical
situation, the magnetic fluid most likely spreads inhomogeneously
inside the tumor. Therefore, numerical analysis was performed to
analyze the distribution of Dw inside tumors, taking into account
the analytical analysis based on ellipsoidal cavities. The tumor
model that was used in the numerical analysis was based not only
on the analytical analysis, but also on the feasibility of building
such a model experimentally and utilizing the GMR for analyzing
Dw inside tumor models. The shape of the tumor modeled
numerically was cylindrical. Even though tumors are assumed to
be spherical in most studies, we chose cylindrical cavities instead
because spherical cavities are difficult to make using agar or other
materials used for making experimental phantoms; the N for
cylindrical cavities (0.3116) is very close to the N for spherical
cavities (0.33) [50].
A two-dimensional finite element model (FEM) of a double-
cavity tumor was simulated in COMSOLH to obtain numerical
results for d in a cylindrical container filled with different
concentrations of magnetic fluid. The model was meshed with
‘Lagrange-Quadratic’ elements, meaning that the solution was
approximated with second degree polynomials. A Quasi-statics
analysis was carried out; an approximation that can be considered
valid given that the frequency was 100 Hz, and that the model was
considerably smaller than the wavelength.
The numerical model is shown in Figure 2 (A). Exploiting the
symmetry of cylinders about their central axis, and about a plane
through their center, only a quarter section of the cylinder was
modeled. There are two cylindrical cavities, cavity 1 (C1) and
cavity 2 (C2), enclosed in an environment (E); C1 and C2
represent two regions inside a tumor, each having a different Dw,
corresponding to the non-uniformity of the tumor. The side
lengths of C1 and C2 are 4 and 15 mm, respectively; when
revolved in 3-D to a full cylinder these side lengths correspond to a
diameter and height of 8 mm for C1 and 30 mm for C2. The r-
axis is parallel to the diameter of the cylinder and the z-axis is
perpendicular to the diameter of the cylinder. The subdomain and
boundary settings are shown in Figure 2 (A). An electrical
conductivity (s) value of 1 S/m and a relative permittivity (er)
value of 161010 was assumed for C1 and C2 (agar and magnetic
Figure 1. Analytical model for estimating magnetic fluid weight density inside a tumor. Magnetic flux density inside and outside a
magnetic fluid-filled ellipsoidal cavity. The flux lines pass through the empty cavity (A) but converge in the cavity with magnetic fluid (B), thus leading
to a difference in the magnetic flux density inside and outside the cavity.
doi:10.1371/journal.pone.0081227.g001
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fluid media) based on [51–60]. E was assumed to be air, so s was
set to 0 S/m and er to 1. Two simulations were performed, one for
the case where Dw inside C1 (Dwi) was less than the Dw inside C2
(Dwo) and another for the case where Dwi . Dwo. For the case Dwi
, Dwo, m* in C1 was set to 1.00242 and m* in C2 was set to
[1.00242, 1.01359, 1.01889, 1.02742, 1.03540, 1.04143, 1.0453],
and for the case Dwi . Dwo, m* in C1 was set to [1.00242,
1.01359, 1.01889, 1.02742, 1.03540, 1.04143, 1.0453] and m* in
C2 was set to 1.00242. The boundary of the surrounding
environment was considered electrically insulating (Neumann
condition) because in the experimental situation the magnetic flux
lines will continue to infinity. The common boundary between the
two cavities and the environment was set to ensure axial
symmetry, and the boundary opposite to this was given a magnetic
potential. The uniform magnetic flux density and the magnetic
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The applied magnetic flux density B (B0) was set to 0.1 mT; the
reason for choosing this value was because the mid-point of the
operating region of the sensor (the maximum dc sensitivity-linear
region) was approximately 0.1 mT. Substituting B= 0.1 mT and
r= 0.4 m (radius of the model) into equation (8), Ah was calculated
to be 0.02 Wb/m.
Figure 2 (B) shows the discretized model consisting of 64517
elements. C1 and C2 had more refined meshes than E because the
analysis of magnetic flux distribution was studied in detail in these
regions; C1, C2 and E had 4040, 55774 and 4703 mesh elements
respectively. Figure 2 (C)-(i) shows the solved model for Dwi , Dwo
and Figure 2 (C)-(ii) for Dwi . Dwo. Figure 2 (C)-(i) demonstrates
that the magnitude of B in C1 is lower than C2, and Figure 2 (C)-
(ii) demonstrates that B is higher in C1 than in C2, thus
corresponding to the Dw values in C1 and C2. These models were
used to obtain numerical results for d as a function of r and Dw; B1
(r, 0) corresponded to the sensing signal, while B0 (r, 20 mm)
corresponded to the applied magnetic flux density outside the
tumor model. The results obtained were used to introduce a basic
methodology to analyze the magnetic fluid distribution inside a
tumor that has potential to be expanded to tumors with many
areas of non-uniformity (a multi-cavity model), which is quite
possibly encountered regularly in clinical MFH treatment.
3. GMR Probe
GMR sensors have several advantages over other magnetic
sensors when utilized for biomagnetic measurements; GMR
sensors require only a small B to change their resistance (highly
sensitive to minute changes in magnetic flux densities), and have
advantages with respect to size, cost, power and thermal stability
compared to commonly used magnetic sensors such as SQUID,
Hall, search coil, or fluxgate sensors [61–67]. Furthermore, GMR
sensors are easily energized by applying a constant current and the
output voltage is a measure of B, so they are ideal for low cost
applications.
The GMR probe that was designed and fabricated has a needle-
shaped detecting part as shown in Figure 3 (A)-(i). The length and
diameter of the needle are 20 mm and 310 mm, respectively. By
having a sensor on the needle, the probe can be made compact,
and in the event that a detection element is attached to the needle,
the influence due to the shape of the substrate can be reduced to a
certain extent. Aluminum titanium carbide, a sintered material of
aluminum oxide and titanium carbide, was used as the base
material to make the needle mechanically strong, since such a fine
needle could be expected to break easily due to a lack of rigidity.
The needle-shaped detecting part consists of a substrate (to which
a machining process was applied in order to cut it to a needle
shape), four spin valve GMR elements formed of thin films on the
surface of the substrate, four connection/bonding pads, lead
conductors for electrically connecting the spin valve GMR
elements to the connection/bonding pads, and a protection film
for covering the spin valve GMR elements and lead conductors,
except parts of the connection/bonding pads. The connection/
bonding pads were formed by a bump layer of Cu, and a bonding
pad layer of Au that was laid on the bump layer. Diamond like
carbon was used as the surface modifying layer since it is
biocompatible.
The spin valve GMR sensors, connection/bonding pads and
lead conductors were formed on a wafer by a wafer process
utilizing thin film photolithography techniques. The needle has a
sensing GMR (GMR 1) element at the tip and reference GMR
elements (GMRs 2–4) at the root near the connection/bonding
pads as shown in Figure 3 (A)-(i). The GMR sensing elements were
connected in a Wheatstone bridge circuit to reduce bias and noise
signals as shown in Figure 3 (A)-(ii). Due to limitations in the
fabrication process it is very difficult to obtain exactly the same
resistances for the sensing elements, giving rise to an offset in the
bridge circuit. To compensate for this imbalance the lengths and
widths of the lead conductors connecting the sensing elements
were adjusted accordingly, as shown in Figure 3 (A)-(ii). The
sensing GMR element measures the magnetic flux density inside
the tumor, while the reference elements are exposed to the applied
magnetic flux density; this enables the probe to estimate B0 and B1
simultaneously. The bridge output was connected to a preampli-
fier (AD 524 precision instrumentation amplifier) inside the probe,
which in turn was connected to a Mini B USB connector, as
shown in Figure 3 (B)-(i). There are two high pass filters on the
differential inputs to the AD524 (IN+ and IN-) to eliminate signals
at very low frequencies (cutoff frequency of 1 Hz), and the
amplification was set to 100V/V (40 dB), as shown in Figure 3 (B)-
(ii). Two bypass capacitors (10 nF) were used to dampen AC
components and noise. The fabricated probe with the USB
connector is shown in Figure 3 (C). The casing that houses the
needle and the flexible printed circuit board was made from
UNILATETM of UNITKA, which is a polyethylene telephthalate
composite resin. However, as a general rule, the case must be
made of any material that is non-magnetic due to the high
sensitivity requirements for low magnetic flux measurements.
When the tip of the needle is inserted into a magnetic medium, the
resistance of the sensing GMR element changes, triggering an
output voltage at the Wheatstone bridge. This enables the
calculation of d, which is correlated to Dw.
GMR Probe for Analyzing Magnetic Fluid in Tumors
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4. Experimental Setup
Agar powder with a jelly strength of 400–600 g/cm2 by Wako
Company was used to make experimental tumor models. To make
pure solidified agar, the concentration requirement was 0.5 g agar
powder per 100 ml distilled water. The agar powder was mixed
with distilled water at boiling or near boiling temperatures. Once
the powder was melted and mixed well with distilled water, the
agar/water complex was placed in the refrigerator to solidify.
Cylindrical agar models, with diameters and heights of 8 and
30 mm (N= 1), respectively, were made to simulate tumors with
two cavities. The cylindrical agar models were injected with
various weight densities of a water-based magnetic fluid (Taiho
industries Co. Ltd, original weight density 40% (40 mg/ml)) to
simulate magnetic fluid filled tumors. The magnetic fluid weight
densities used in the experiments (0.814%–2.713%) were chosen
for two reasons: i) Even though magnetic fluids like ResovistH used
in MFH are clinically approved, surgeons still prefer to perform
frequent, repeated treatments with low densities (generally
,2.8%), and ii) the fluid density may very well decrease once
injected into the tumor by spreading to neighboring tissues, and a
fraction of this density may still remain after treatment. Therefore,
it is important to be able to detect concentrations much smaller
than 2.8%. Moreover, the lower the weight density that can be
detected and estimated, the wider the area of distribution that can
be mapped by the GMR probe. It follows that if the GMR probe is
sensitive enough to detect and estimate such low weight densities,
Figure 2. Numerical modeling. (A) 2-D, axial-symmetric model, (B) meshed model, and (C) solved model for the cases (i) Dwi , Dwo and ii) Dwi .
Dwo.
doi:10.1371/journal.pone.0081227.g002
GMR Probe for Analyzing Magnetic Fluid in Tumors
PLOS ONE | www.plosone.org 5 November 2013 | Volume 8 | Issue 11 | e81227
it would naturally be able to detect and estimate higher weight
densities, if needed.
A uniform magnetic flux density is an important requirement
for the estimation of Dw when using the probe. A Lee-Whiting
type coil [68] was designed and fabricated, producing a 0.001%
fluctuation from the center of the coil in approximately 35% of the
outer coil spacing along the z-direction and 25% of the diameter of
the coils in the r-direction. The design of the Lee-Whiting coil is
shown in Figure 4 (A) and the analytical results are shown in
Figure 4 (B–C). The distance between the active GMR sensor at
the tip and the reference GMR sensors near the pads is
approximately 20 mm. Ideally, the tip of the active GMR sensor
is at the center of the Helmholtz coil, and the GMR reference
sensors are 20 mm above the Helmholtz coil in the z-direction.
The fluctuation of B, calculated at 20 mm from the center of the
designed coil, is 2.661025%. The magnetic flux density change
due to Dw is required to be higher than this fluctuation in order to
obtain reliable data.
The experimental setup is shown in Figure 5 (A). The
experiments were performed in an isolated room where only the
instruments used in the experiments were present. Proper
alignment of the experimental setup was ensured by using liquid
Figure 3. The giant magnetoresistance probe. (A) (i) Needle sensor, and (ii) Wheatstone bridge design of the sensors. (B) (i) Probe interface
circuit, and (ii) amplifier circuit. (C) Fabricated probe with the USB connector.
doi:10.1371/journal.pone.0081227.g003
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balances. Using a micro-positioner, the needle was precisely
placed at analysis points of the cavity for various values of r. The
output (Gain = 100) of the instrumentation amplifier was then fed
into a digital lock-in amplifier (NF Electronics LI5640) as shown in
Figure 5 (B). The lock-in amplifier was used to measure the signal
at 100 Hz with a bandwidth of 1 Hz. A value was obtained as an
average of five readings taken at 5 second intervals once the signal
settled after 60 s.
Results and Discussion
1. Numerical Results of the Magnetic Flux Density
Distribution inside Cylindrical Cavities
The numerical analysis performed showed a clear change in d
when moving along the (r, 0) axis, from one cavity with a density
Dw1 to another cavity with a density Dw2. This change was most
significant when d was obtained along the radial (r) axis while the
axial (z) axis was 0. In the numerical model, both the inner and
outer cavities were centered at (0,0) mm. As shown in Figure 6 (A)-
(i), there is a significant increase in the magnetic flux density values
when moving from the inner cavity (C1) to the outer cavity (C2).
This increase is proportional to the Dw values. For example, the
highest change is observed for Dwo = 2.713% and the lowest for
Dwo = 0.814% (there is no significant change when Dwo is 0.145%
since then Dwo = Dwi). These first two observations concur with
equation (5), which shows that d is proportional to Dw. In addition,
d is relatively stable from r= 8–12 mm, between the outer
boundaries of the two cavities (r= 4 and 15 mm). Therefore, in
the outer cavity, Dw can be estimated anywhere along r= 8–
12 mm. For the case when Dwi is higher than Dwo, there is a
significant decrease in the B values when moving from C1 to C2,
and this decrease, as for the case when Dwi is lower than Dwo, is
proportional to the Dw values (Figure 6 (A)-(ii)). However, since the
boundaries of C1 are extremely close to each other (4 mm
compared with 11 mm in Figure 6 (A)-(i)), the most suitable point
for estimation is at the center of the tumor model, at (0,0).
Therefore, the GMR probe can be utilized to obtain signals
corresponding to changes in magnetic flux densities by inserting
the needle into these points (at the center (0,0) of the inner cavity
and at a point in the stable region of the outer cavity).
Next, several tumor models with different combinations of
weight densities and analysis points were considered in order to
Figure 4. The Lee-Whiting coil. (A) Coil design, (B) (i) magnetic flux distribution in the z-direction, (ii) magnetic flux density distribution in the r-
direction, and (C) fluctuation of the magnetic flux density from the center of the coil.
doi:10.1371/journal.pone.0081227.g004
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investigate how values, estimated at a point in the stable region
and at the center of the tumor model, compare with analytical
values based on ellipsoidal cavities. In Figure 6 (B)-(i), combination
1 shows a cylindrical cavity where Dwi equals Dwo and the weight
density is estimated at the center of the cavity. In combinations 2
(Dwi , Dwo) and 3 (Dwi . Dwo), the weight density is also
estimated at the center of the cavity. However, in combinations 4
(Dwi , Dwo) and 5 (Dwi . Dwo), the weight density is estimated at
10 mm from the center of the tumor model at (0,10) mm; this
point is in the stable region depicted in Figure 6 (A)-(i). Figure 6
(B)-(ii) shows the numerical results obtained for these five
combinations compared with a spherical cavity (N= 0.33). For
all combinations, d is proportional to Dw. Also, since N is lower for
cylindrical cavities (0.3116) than for spherical cavities (0.33) the
trendlines for all five combinations are higher than the analytical
line (see equation (5)). Numerical results for combinations 2 and 3
are very close to combination 1. Combination 1 is the ideal case,
where there is no distribution of magnetic fluid and Dw can thus be
estimated at the center of the tumor model. Although Dw is
estimated at the center of the cavity for both combinations 2 and
3, the tumor model does not have a uniform distribution of Dw;
Dwi and Dwo are different inside the two cavities. However, when
Dw is estimated at the center, the result is very close to the
numerical results This observation leads us to conclude that if
there were a given volume of tumor in the middle with a certain
weight density, surrounded by lower or higher weight densities, the
GMR probe would quite possibly still be able to measure B at the
center of the tumor and estimate Dw by the difference between the
flux densities inside and outside the tumor. Combinations 4 and 5
showed the highest variance in the change in magnetic flux
densities compared with the numerical results, since B was
estimated at a point in the stable region (0,10) mm and not at
the center of the tumor model (0,0). B is most uniform at the center
of the tumor model and dominant in the z-direction. The larger
change in magnetic flux densities observed for combinations 4 and
5 can be attributed to the decrease in the uniformity of the
magnetic flux density values along the r-axis; flux density
components in directions other than the z-direction decrease the
magnitude and uniformity in the z-direction.
Figure 5. (A) Experimental setup, and (B) schematic of the data analysis setup.
doi:10.1371/journal.pone.0081227.g005
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Figure 6. Numerical results. (A) The magnetic flux density distribution when (i) Dwi , Dwo, and (ii) Dwi . Dwo. (B) (i) Different combinations of
magnetic fluid weight densities to be estimated and surrounding media with varying weight densities. (ii) Comparison of magnetic fluid weight
densities for surrounding mediums with different weight densities.
doi:10.1371/journal.pone.0081227.g006
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Two important points can be gathered from the numerical
results: i) There is a significant difference in the change in the
magnetic flux density proportional to Dw in tumor models with
two cavities, where each cavity has a different Dw, and ii) this
change in magnetic flux density compares well with analytical
results, leading to a firm basis for experimental analysis. Hence,
this methodology can be used to not only detect but also to
estimate Dw in a double-cavity tumor model.
2. Experimental Analysis
A small signal AC sensitivity characterization of the GMR
probe was carried out for the sensing GMR element (GMR 1)
along the sensitive axis of GMR 1 as shown in Figure 7 (A). The
Lee-Whiting coil was used to apply a uniform B of 0.09 mT at a
frequency of 100 Hz. The coil was driven by a sinusoidal current
provided by a function generator (Sony Tektronix AFG310)
connected to a high-speed power amplifier (NF Electronics 4055).
The probe output and the output of a current clamp (Hioki 3274),
measuring the current in the coil, were connected to an
oscilloscope (Yokogawa DL4100). The waveforms in the oscillo-
scope were transferred to a computer by a general purpose
interface bus (GPIB) to evaluate the AC sensitivity. The 100 times
amplified small signal AC sensitivity of the GMR sensor was
approximately 2800 mV/mT as shown in Figure 7 (B).
The main objective of the experimental analysis was to observe
if the GMR probe could be used to analyze the distribution of two
magnetic weight densities in different areas of a single agar tumor
model. Figure 8 (A) shows the schematic of the double-cavity agar
tumor model. The dimensions of the model are the same as the
model used for numerical analysis. Furthermore, the needle tip
insertion points are based on the numerical analysis and placed at
the center of the model (0,0) and 10 mm to the right (0,10) and left
(0,210), of the center. The position along the z-axis is 0. The
distance between the GMR sensor at the tip and the references
sensors is 20 mm. Since the height of the tumor model from the
top to the center is 15 mm, the reference sensors are 5 mm above
the top of the tumor model, when the needle is at the center;
therefore, the reference sensors are exposed to the applied B. In
this way the GMR probe is able to measure both the magnetic flux
density inside the cavity (B1) and outside the cavity (B0)
simultaneously.
Initial experiments were performed with agar tumor models
without magnetic fluid to observe the response of the GMR probe.
Ideally, the differential signal would be 0, since the relative
permeability of agar and air is 1; therefore, both B1 and B0 should
be the same. However, an average change in magnetic flux density
Figure 7. GMR probe characterization. (A) Experimental setup for characterization, (B) small-signal AC sensitivity at 100 Hz.
doi:10.1371/journal.pone.0081227.g007
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of 0.03% was observed. This change in magnetic flux density
corresponds to a Dw of 0.0268%, the limit of resolution of the
current setup.
Figure 8 (B)-(i) shows the experimental results for a double-
cavity agar model where Dwi is lower than Dwo. Three Dw values
were used in three different mixtures. In mixture 1 (denoted by
diamond data points), Dwi is 0.814% and Dwo is 1.642%; in
mixture 2 (denoted by square data points), Dwi is 0.814% and Dwo
is 2.713%; and in mixture 3 (denoted by triangular data points),
Dwi is 1.642% and Dwo is 2.713%. Note that the differences in the
change in magnetic flux densities for all these mixtures are more
than the average noise signal of 0.03%. The GMR probe was
inserted at (0,210) mm, then (0,0) mm, and finally at (0,10) mm.
The experimental results demonstrate a significant change in d for
all three mixtures when the probe was moved through the agar
model. d decreased when the needle was moved from (0,210) mm
to (0,0) mm, because Dw at (0,210) mm is higher than Dw at (0,0)
mm, and then it increased when the needle was subsequently
moved to (0,10) mm because of the higher Dw there, giving rise to
a ‘trough’ shape. The change is also proportional to the change in
Dw. For example, the change in d for mixture 2 is highest because
the difference in Dw is the highest (2.713%20.814% = 1.8990%).
Figure 8. Experimental analysis. (A) Schematic of the double-cavity cylindrical agar tumor model. (B) Magnetic fluid distribution analysis in
double-cavity agar models. (i) Dwi , Dwo and (ii) Dwi . Dwo. (C) Correlation of experimental data with analytical results.
doi:10.1371/journal.pone.0081227.g008
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The decrease in d is not so clear-cut for mixtures 1 and 3, because
the difference in their Dw values is very small (0.8280% for
mixture 1 and 1.0710% for mixture 3). Figure 8 (B)-(ii) shows the
results for a double-cavity tumor model with the same three
mixtures as in Figure 8 (B)-(i), but for the case when Dwi is greater
than Dwo. The experimental results show a significant change in d
and, as expected, the behavior is opposite to that shown in Figure 8
(B)-(i), since Dw is highest at (0,0) mm, giving rise to a ‘peak’.
Again, the changes in d are highest for mixture 2, because it has
the largest difference in the magnetic fluid weight density
(Dwi-Dwo) and the change is not so obvious for mixtures 1 and
3. All the data points in Figure 8 (B) were also compared to d
values obtained by analytical analysis (dashed lines in Figure 8 (B)).
It can be seen that the measured points do not deviate greatly from
the analytical lines; a deviation corresponding to the difference in
the demagnetization values between a spherical and cylindrical
cavity is expected.
In general, inside a uniformly magnetized ferromagnetic body
(m*.1), B is not uniform. The only geometric shape in which it is
uniform in practice is an ellipsoid. In all non-ellipsoidal shapes, the
demagnetizing factor N, is used to approximate the internal
magnetic flux densities. Most studies have assumed that tumors are
spherical because they are easiest to examine theoretically. For a
spherical tumor, s= 1 and N= 1/3; if a tumor is long and thin
(rod-shaped), s = ‘ and N= 0; and if a tumor is short and flat
(disk-shaped), s= 0.5 and N= 0.527 [49]. In Figure 8 (C), the
values for a rod-shape are used as the upper limit of error and
those for a disk shape as the lower limit of error. These limits are
for cavities that have a uniform magnetic fluid distribution and
hence a uniform permeability inside (Dwi = Dwo), and d is
calculated at the center of the cavity. The magnetic fluid weight
densities detected inside the agar cavities in Figure 8 (B) are shown
in the graph. These points are the average of data values at each
point in the cavity in Figure 8 (B). The average values estimated at
the center are denoted by N, and the values estimated at (0,210)
mm and (0,10) mm are denoted by6. The average signal, when
no magnetic fluid is present in the agar cavities, is also added to the
graph and can be considered as the average noise signal. As can be
seen from Figure 8 (C), all the experimental results fall within the
upper and lower limits of N. This shows that unless the tumor has
a highly irregular shape, the proposed methodology provides a
sound basis for estimating magnetic fluid weight densities inside
tumor formations.
3. Discussion
The average noise signal observed when there was no magnetic
fluid present in agar cavities has several sources. Besides
electromagnetic and instrumentation noise, the Lee-Whiting coil
may be the dominant contributor. An analysis was performed to
show how errors in coiling and construction could affect the
uniformity of the applied magnetic flux density. With reference to
Figure S1 (A), coils 1–1 and 1–2 can be reasonably expected to
shift up to +/2 2 mm in the r- and z-directions during assembly.
The errors at 20 mm in the z-direction (the distance between the
active and reference GMR sensors) due to these shifts are shown in
Figure S1 (B). It can be seen that the fluctuations increase 100 fold
for +/2 1 mm shifts and 1000 fold for +/2 2 mm shifts.
Moreover, if the current distribution is considered to be a square
(due to actual coiling) instead of a point (as assumed in the
analytical analysis), the error increases to 461025%.
The reason for fluctuations in Figure 8 (B) and (C), which are
larger than the fluctuations due to the difference in N values for a
sphere and cylinder, is most probably due to errors in positioning
of the needle tip, since B is highest at the center and decreases in
both positive and negative directions along the needle insertion
axis (the z-axis). Another plausible reason is that remainders of
magnetic fluid accumulate at the needle, resulting in a cumulative
effect with each insertion, even though the sensor was dipped in
alcohol after each insertion to clean the agar and magnetic fluid
mixture.
If the GMR needle probe is to be used in vivo it is also important
to consider bodily fluid and tissues that are conductive, and the
implications caused by exposing them to high frequency fields.
Therefore, it is important to perform analysis at very low AC
frequencies since high-frequency magnetic flux can induce eddy
currents on conductive media in the body and the resulting
electromagnetic fields have the possibility of modifying the GMR
needle probe measurements (please see Figure S2). No discernible
difference was observed in the B distribution at frequencies of 100
and 1000 Hz (Figures S2 (A)-(i) and (ii) and Figures S2 (B)-(i) and
(ii)), and the distributions in both cases were comparable to the
numerical results obtained in Figures 6 (A)-(i) and (ii) for s= 1 S/
m. However, the effect of eddy currents was seen at 10000 Hz
(Figure S2 (A)-(iii) and Figure S2 (B)-(iii)).
The cavities used to simulate cancerous tumors in this research
were limited to cylindrical shapes. Currently, it is assumed that
tumors are spherical in shape; however, in reality they could be
any shape. The orientation of the cavity should also be considered.
Cylindrical cavities used for the experiments are symmetrical in
the r- and z-directions, but tumor growth inside the body can be in
any direction. Hence, it is necessary to perform more experiments
with different shapes and orientations of cavities.
Conclusion
This paper investigated the feasibility of analyzing the
distribution of magnetic fluid, as used in MFH therapy, utilizing
a GMR probe. Once the distribution of the fluid is known, the
magnitude and frequency of the applied magnetic flux density can
be tuned to optimize the effects of MFH therapy. The key feature
of this research is the GMR probe that was designed and
fabricated to be inserted into the human body in a minimally-
invasive way. Small-signal AC characterization showed that the
GMR probe has a sensitivity of 2800 mV/mT. An analytical
model was presented to estimate magnetic fluid weight density
(Dw) inside tumors using the GMR probe. The difference in the
magnetic flux density inside (B1) and outside (B0) a magnetic fluid-
filled cavity, under the influence of a uniform magnetic flux
density, was quantified by numerical analysis. B1 and B0 were then
expressed in terms of the relative permeability and Dw of the
magnetic fluid, leading to a method of estimating Dw. The needle
of the GMR probe has an active GMR sensing element at the tip
and three reference GMR sensing elements 20 mm further up the
needle. This unique design allows it to measure both B1 and B0
simultaneously. Double-cavity agar tumor models were made with
different values of Dw. Three magnetic fluid weight densities
(0.814%, 1.642% and 2.713%) were tested in three combinations.
The Dw values tested were less than 2.8%, which corresponds to
typical values used in clinical applications. A Lee-Whiting coil was
designed and fabricated to provide a uniform magnetic flux
density of 0.1 mT at a frequency of 100 Hz. The experimental
results showed that the GMR probe was able to detect different
weight densities inside the agar tumor model, and that Dw was
proportional to the change in magnetic flux density (B1 2 B0). The
experimental results corresponded well with analytical and
numerical results; the higher the difference between the magnetic
fluid weight densities, the higher the difference between the
changes in magnetic flux densities obtained by the GMR probe.
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The results were also within the error limits due to the shape of the
cavity, considering rod-shaped and disk-shaped cavities. This
indicated that the magnetic fluid weight density can be estimated
by the GMR probe inside tumors with a wide range of different
shapes. Based on the average noise signal of 0.03%, which is the
change in the magnetic flux density for agar cavities without any
magnetic fluid, the limit of Dw that could be estimated with the
current setup is 0.0268%. The experimental results obtained in
this paper suggest the possibility of extending and using this
methodology for obtaining magnetic fluid weight density maps in
tumors with an inhomogeneous distribution of magnetic fluid.
Supporting Information
Figure S1 (A) Possible errors due to construction and
coiling. (B) Fluctuations in the magnetic flux density at 20 mm in
the z-direction from the center of the coil system, when the radius
or the distance between coils 1–1 and 1–2 is shifted 2 mm.
(TIF)
Figure S2 Influence of eddy currents on the distribution
of magnetic flux density. (A) Magnetic flux density distribution
when Dwi , Dwo, at frequencies of (i) 100 Hz (ii) 1000 Hz and (iii)
10,000 Hz. (B) Magnetic flux density distribution when Dwi .
Dwo, at frequencies of (i) 100 Hz (ii) 1000 Hz and (iii) 10,000 Hz.
(TIF)
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